Sophisticated imaging methods, such as computed tomography, magnetic resonance imaging and positron emission tomography, play an increasingly important role in the management of head and neck cancer. Pretreatment imaging findings have predictive value for patient outcome, independently from the currently used TNM classification, and may be used to tailor treatment to the individual patient. Based on per-treatment imaging, individualised replanning during radiotherapy may ameliorate tumour control rates and reduce toxic effects to normal tissues. Early posttreatment imaging studies contain important prognostic information, and allow selection of patients for further treatment or watchful waiting.

Author

Robert Hermans

Contact Details

Corresponding address:
Robert Hermans, MD, PhD,
Department of Radiology,
University Hospitals Leuven,
Herestraat 49, B-3000 Leuven,
Belgium

Reference

ICIS Cancer Imaging Volume 6 Special Issue A
DOI: 10.1102/1470-7330.2006.9028

Date Posted

31 October 2006

Print PDF

Size

5.94 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	23 seconds
ADSL 512Kb/s (Broadband):	1 minute 35 seconds
64 Kb/s (ISDN):	12 minutes 40 seconds
33.3 Kb/s (Typical Modem):	24 minutes 22 seconds

Screen PDF

Size

862.12 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	3 seconds
ADSL 512Kb/s (Broadband):	13 seconds
64 Kb/s (ISDN):	1 minute 47 seconds
33.3 Kb/s (Typical Modem):	3 minutes 27 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 66356, London, E14 1GW. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.